Simplex Trading, LLC Orgenesis Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$1.38 - $2.38 $420 - $725	305 Added 1051.72%	334 $0
Q2 2022 Aug 03, 2022	SELL	$1.8 - $3.74 $3,486 - $7,244	-1,937 Reduced 98.52%	29 $0
Q1 2022 May 02, 2022	SELL	$2.31 - $3.72 $5,791 - $9,326	-2,507 Reduced 56.05%	1,966 $6,000
Q4 2021 Feb 23, 2022	SELL	$2.61 - $4.9 $11,797 - $22,148	-4,520 Reduced 50.26%	4,473 $12,000
Q2 2021 Aug 12, 2021	BUY	$4.19 - $5.88 $37,680 - $52,878	8,993 New	8,993 $45,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.